Major Depressive Disorder in Iran: Epidemiology, Health Care Provision, Utilization, and Challenges

Masoumeh Amin-Esmaeili ^1,2 , Behrang Shadloo ¹ , Afarin Rahimi-Movaghar ¹ * , Seyed Mehdi Samimi Ardestani ³ , Ahmad Hajebi ⁴ , Shahab Khatibzadeh ⁵, Vandad Sharifi ⁶, Roya Samadi ⁷, Mohammad Taghi Yasamy ⁸ , Mehran Zarghami ⁹ , Farshad Farzadfar ¹⁰ , Saeid Shahraz ^5,11

Cited by CrossRef: 3

1- Ma J, Zhou H, Fu Q, Lu G. Facilitators and barriers in the development and implementation of depression prevention and treatment policies in China: a qualitative study. BMC Public Health. 2023;23(1) [Crossref]

2- Nasirpour N, Esmailzadehha N, Hajebi A, Savari E, Ghanbari B, Motevalian A. Preexisting depression and COVID-19: a cohort study on the risk of susceptibility and hospitalization. BMC Psychiatry. 2023;23(1) [Crossref]

Submit Your Paper Notification Instructions for Authors Aims and Scope Editorial policies Editorial Board AIM old site Archive

About Us

A Monthly Peer-Reviewed Medical Journal Published by the Academy of Medical Sciences of the I.R. Iran; Indexed in PubMed/MEDLINE, ISI Web of Science, EMBASE, SCOPUS, CINHAL, PASCAL, CSA, SID, ISSN: Print 1029-2977, Online 1735-3947.The impact factor of Archives of Iranian Medicine according to Journal Citation Reports® (JCR®) 2016 is 1.20.